Showing results (2481-2490 of 2,695) with videos related to

Sort By:
Pageof 270
The Lancet. Infectious Diseases|November 23, 2019
Global and regional estimates of the contribution of herpes simplex virus type 2 infection to HIV incidence: a population attributable fraction analysis using published epidemiological dataKatharine J Looker, Nicky J Welton, Keith M Sabin, et al.
The Lancet. Infectious Diseases|November 13, 2020
Safety and immunogenicity of a synthetic carbohydrate conjugate vaccine against Shigella flexneri 2a in healthy adult volunteers: a phase 1, dose-escalating, single-blind, randomised, placebo-controlled studyDani Cohen, Jacob Atsmon, Cécile Artaud, et al.
The Lancet. Infectious Diseases|September 5, 2014
A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort studyLai Kin Yaw, James Owen Robinson, Kwok Ming Ho
The Lancet. Infectious Diseases|June 21, 2016
Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: systematic review and guidelinesBrendan J McMullan, David Andresen, Christopher C Blyth, et al.
The Lancet. Infectious Diseases|June 18, 2016
Antimicrobial stewardship across 47 South African hospitals: an implementation studyAdrian J Brink, Angeliki P Messina, Charles Feldman, et al.
The Lancet. Infectious Diseases|October 30, 2020
What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2Susanne H Hodgson, Kushal Mansatta, Garry Mallett, et al.
The Lancet. Infectious Diseases|June 10, 2021
Arterolane-piperaquine-mefloquine versus arterolane-piperaquine and artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trialMainga Hamaluba, Rob W van der Pluijm, Joseph Weya, et al.
The Lancet. Infectious Diseases|October 28, 2021
Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trialJeanne Rini Poespoprodjo, Faustina Helena Burdam, Freis Candrawati, et al.
The Lancet. Infectious Diseases|October 29, 2021
Safety, pharmacokinetics, and antimalarial activity of the novel plasmodium eukaryotic translation elongation factor 2 inhibitor M5717: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study and volunteer infection studyJames S McCarthy, Özkan Yalkinoglu, Anand Odedra, et al.
The Lancet. Infectious Diseases|May 2, 2022
A call for loiasis to be added to the WHO list of neglected tropical diseasesKathryn H Jacobsen, Bailey C Andress, Elina A Bhagwat, et al.
Pageof 270